IBJNews

CVS to pay $858K over inflated drug claims

Back to TopCommentsE-mailPrintBookmark and Share

Indiana Attorney General Greg Zoeller says the state will get $858,000 from CVS Pharmacy Inc. to settle allegations that the company overcharged Medicaid programs.

The amount represents Indiana's share of a $17.5 million settlement reached last week with 10 states and the federal government.

The Justice Department says the settlement resulted from an investigation into claims CVS collected more than it should have from Medicaid for filling prescriptions for people who have other insurance as well. Typically, pharmacies can only bill Medicaid for the amount of a patient's co-payment in those situations.

Zoeller said Thursday the total state settlement paid to the Indiana Medicaid program will be $858,176, including $572,117 for the state's share of Medicaid restitution and $286,058 for additional recoveries.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT